ATE309267T1 - Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür - Google Patents
Methode zur proliferation und differenzierung von b-zellen und verwendungen dafürInfo
- Publication number
- ATE309267T1 ATE309267T1 AT95918912T AT95918912T ATE309267T1 AT E309267 T1 ATE309267 T1 AT E309267T1 AT 95918912 T AT95918912 T AT 95918912T AT 95918912 T AT95918912 T AT 95918912T AT E309267 T1 ATE309267 T1 AT E309267T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- proliferation
- differentiation
- proliferating
- present
- Prior art date
Links
- 230000004069 differentiation Effects 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 3
- 230000002062 proliferating effect Effects 0.000 abstract 2
- 210000000628 antibody-producing cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/52—CD40, CD40-ligand (CD154)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23458094A | 1994-04-28 | 1994-04-28 | |
PCT/US1995/005448 WO1995029935A1 (en) | 1994-04-28 | 1995-04-28 | Method for proliferating and differentiating b cells, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE309267T1 true ATE309267T1 (de) | 2005-11-15 |
Family
ID=22881963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95918912T ATE309267T1 (de) | 1994-04-28 | 1995-04-28 | Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür |
Country Status (10)
Country | Link |
---|---|
US (2) | US5817516A (de) |
EP (1) | EP0763057B1 (de) |
JP (1) | JP3881691B2 (de) |
AT (1) | ATE309267T1 (de) |
CA (1) | CA2188165C (de) |
DE (1) | DE69534595T2 (de) |
DK (1) | DK0763057T3 (de) |
ES (1) | ES2251719T3 (de) |
MX (1) | MX9605088A (de) |
WO (1) | WO1995029935A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962406A (en) * | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
US7405270B2 (en) * | 1991-10-25 | 2008-07-29 | Immunex Corporation | CD40-Ligand lacking native-pattern glycosylation |
EP0763057B1 (de) * | 1994-04-28 | 2005-11-09 | Boehringer Ingelheim Pharmaceuticals Inc. | Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür |
US6465251B1 (en) | 1996-11-13 | 2002-10-15 | Dana-Farber Cancer Institute, Inc. | Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin |
WO1998021314A2 (en) * | 1996-11-12 | 1998-05-22 | Dana-Farber Cancer Institute | Method of promoting b-cell proliferation and activation and of modulating the immune system |
US7070771B1 (en) | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
EP2039368A3 (de) | 1999-04-30 | 2009-04-01 | La Jolla Institute For Allergy And Immunology | Verfahren zur Vorbeugung der Reaktivierung von latenten Viren und Überwachung der Virenreplikation |
US7786282B2 (en) * | 2001-12-06 | 2010-08-31 | The Regents Of The University Of California | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain |
EP2141228A1 (de) * | 2001-12-18 | 2010-01-06 | Cancer Research Technology Limited | Methode zur Herstellung von proliferierenden und differenzierenden B-Zelllinien |
US7495090B2 (en) * | 2002-05-23 | 2009-02-24 | The Regents Of The University Of California | Nucleic acids encoding chimeric CD154 polypeptides |
ATE488600T1 (de) * | 2002-12-23 | 2010-12-15 | Bristol Myers Squibb Co | Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion |
EP1844073A1 (de) * | 2005-01-31 | 2007-10-17 | Ablynx N.V. | Verfahren zur erzeugung von sequenzen der variablen domäne von antikörpern mit schweren ketten |
DE602006021324D1 (de) * | 2005-08-23 | 2011-05-26 | Iq Corp | Verfahren zur herstellung stabiler b-lymphozyten |
BRPI0819229B1 (pt) * | 2007-11-01 | 2019-01-22 | The Board Of Trustees Of The University Of Arkansas | vacinas para reforçar reações imunes contra eimeria |
WO2010034103A1 (en) * | 2008-09-23 | 2010-04-01 | Héma-Québec | Method for polyclonal immunoglobulin g production by human b cells |
JP5550132B2 (ja) | 2009-10-30 | 2014-07-16 | 学校法人東京理科大学 | 抗原特異的b細胞集団の製造方法 |
EP3610887B8 (de) | 2013-02-14 | 2024-01-24 | The Board of Trustees of the University of Arkansas | Zusammensetzungen und verfahren zur verstärkung von immunreaktionen gegenüber eimeria oder zur begrenzung von eimeria-infektionen |
WO2016002760A1 (ja) | 2014-07-02 | 2016-01-07 | 学校法人東京理科大学 | B細胞集団の製造方法 |
US11043823B2 (en) * | 2017-04-06 | 2021-06-22 | Tesla, Inc. | System and method for facilitating conditioning and testing of rechargeable battery cells |
GB201707238D0 (en) | 2017-05-05 | 2017-06-21 | Univ Oxford Innovation Ltd | Composition |
KR102539610B1 (ko) * | 2020-01-22 | 2023-06-02 | 한국생명공학연구원 | 메모리 b 세포 특이적 분화 유도 방법 및 이의 활용 |
TW202309270A (zh) * | 2021-04-19 | 2023-03-01 | 美商步行魚醫療公司 | 用於細胞療法的b細胞擴增之方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989008114A1 (en) | 1988-02-25 | 1989-09-08 | The General Hospital Corporation | Rapid immunoselection cloning method |
EP0434879A1 (de) * | 1989-12-14 | 1991-07-03 | Schering-Plough | Verfahren zur Herstellung von faktorabhÀ¤ngigen menschlichen B-Zellinien |
DE4216355A1 (de) | 1991-05-16 | 1992-11-26 | Idt Ag Fuer In Vivo Diagnostik | Verfahren zur bereitstellung von antigen-spezifischen b- und t-lymphozyten sowie davon erhaltene monoklonale antikoerper |
CA2121798C (en) | 1991-10-25 | 2007-07-24 | Richard J. Armitage | Novel cytokine |
US5474771A (en) | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
IL104684A0 (en) | 1992-02-14 | 1993-06-10 | Bristol Myers Squibb Co | The cd40cr receptor and ligands therefor |
DE4322330A1 (de) | 1992-08-31 | 1994-03-03 | Behringwerke Ag | Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen |
US5516657A (en) * | 1992-05-11 | 1996-05-14 | Cambridge Biotech Corporation | Baculovirus vectors for expression of secretory and membrane-bound proteins |
AU5098493A (en) | 1992-08-21 | 1994-03-15 | Schering Corporation | Cd40 ligand, anti cd40 antibodies, and soluble cd40 |
US5540926A (en) | 1992-09-04 | 1996-07-30 | Bristol-Myers Squibb Company | Soluble and its use in B cell stimulation |
EP0763057B1 (de) * | 1994-04-28 | 2005-11-09 | Boehringer Ingelheim Pharmaceuticals Inc. | Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür |
-
1995
- 1995-04-28 EP EP95918912A patent/EP0763057B1/de not_active Expired - Lifetime
- 1995-04-28 JP JP52849095A patent/JP3881691B2/ja not_active Expired - Lifetime
- 1995-04-28 DE DE69534595T patent/DE69534595T2/de not_active Expired - Lifetime
- 1995-04-28 DK DK95918912T patent/DK0763057T3/da active
- 1995-04-28 AT AT95918912T patent/ATE309267T1/de active
- 1995-04-28 MX MX9605088A patent/MX9605088A/es unknown
- 1995-04-28 US US08/431,055 patent/US5817516A/en not_active Expired - Lifetime
- 1995-04-28 WO PCT/US1995/005448 patent/WO1995029935A1/en active IP Right Grant
- 1995-04-28 ES ES95918912T patent/ES2251719T3/es not_active Expired - Lifetime
- 1995-04-28 CA CA002188165A patent/CA2188165C/en not_active Expired - Lifetime
-
1997
- 1997-04-24 US US08/858,197 patent/US6297052B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2251719T3 (es) | 2006-05-01 |
EP0763057A4 (de) | 1998-11-11 |
JPH09512441A (ja) | 1997-12-16 |
DE69534595T2 (de) | 2006-05-24 |
CA2188165A1 (en) | 1995-11-09 |
JP3881691B2 (ja) | 2007-02-14 |
US6297052B1 (en) | 2001-10-02 |
US5817516A (en) | 1998-10-06 |
DE69534595D1 (de) | 2005-12-15 |
EP0763057A1 (de) | 1997-03-19 |
CA2188165C (en) | 2007-08-28 |
MX9605088A (es) | 1997-08-30 |
EP0763057B1 (de) | 2005-11-09 |
DK0763057T3 (da) | 2006-03-27 |
WO1995029935A1 (en) | 1995-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE309267T1 (de) | Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür | |
ATE169670T1 (de) | Zellkultursysteme und medien | |
YU45871B (sh) | Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima | |
ATE406435T1 (de) | Methoden zur züchtung von tierzellen | |
ATE153214T1 (de) | Medien zur zellzucht und verfahren dazu | |
DK0414475T3 (da) | Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier | |
DE3476221D1 (en) | Method for obtaining human hepatocytes cultures, cultures obtained thereby and biological and biochemical applications thereof | |
ATE114713T1 (de) | Biomasse zur produktion von virus/virusantigen. | |
ES2176224T3 (es) | Proceso para la produccion de proteina. | |
DE69900936D1 (de) | Elektrolysezelle zur Erzeugung von Gas | |
ATE413451T1 (de) | Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren | |
DE3650468D1 (de) | Methoden zur Verwendung von an humanen Klasse-II-Histokompatibilitätsantigenen mangelnden Zellinien | |
ES2047946T3 (es) | Metodos de cultivos celulares para producir proteina c activada. | |
DE3871322D1 (de) | Verfahren zur kultur von pflanzengewebe. | |
DE69014723D1 (de) | Zellzüchtungsverfahren. | |
ATE49777T1 (de) | Verfahren zur zuechtung von hepatozyten und cozuechtung von hepatozyten und von behandelten epithelien leberzellen. | |
KR940000572A (ko) | 사람 인터루킨- 6 단백질을 생산하는 식물 및 그의 제조방법 | |
FI974043A (fi) | Menetelmä mikrobiologisten näytteiden viljelemiseksi | |
ATE30244T1 (de) | Verfahren und vorrichtung zur kultivierung von mikroorganismen. | |
WO2003060070A3 (en) | Method of identifying novel proteins | |
MX9703386A (es) | Cultivos neurales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0763057 Country of ref document: EP |